Wilms Tumor

Wilms Tumor is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

Basics

Description

  • The most common renal tumor in children; fifth most common pediatric malignancy
  • An embryonal renal neoplasm containing blastemal, stromal, or epithelial cell types
  • System(s) affected: renal/urologic
  • Synonym(s): nephroblastoma

Pediatric Considerations
Occurs predominately in children; rare incidence in late adolescence and adults

Epidemiology

Incidence

  • WT represents 6–7% of all childhood cancers and comprises 95% of renal cancers in children <15 years (1).
  • 650 cases diagnosed annually; incidence of 8.2 cases per 1 million children (1)
  • Median age of diagnosis is 36.5 months (1).

Etiology and Pathophysiology

Genetics

  • Tumors display recurrent gene mutations involved in either early renal development or epigenetic regulation (e.g., chromatin modification, transcription regulation, miRNA) (1).
  • 1/3 of tumors involve mutations of WT1, CTNNB1, or WTX genes (1).
  • Majority occur sporadically; familial inheritance <2% (1)

Risk Factors

More frequent in black children; rare in Asian (1)

General Prevention

Genetic counseling recommended for WT and one major abnormality: overgrowth syndromes, hemihyperplasia, aniridia, mental disability, diffuse mesangial sclerosis; or two minor malformations—inguinal or umbilical hernia, hypospadias, renal abnormalities, ectopic testis (1)

Commonly Associated Conditions

  • Overgrowth syndromes: Beckwith-Wiedemann syndrome, isolated hemihyperplasia, Perlman syndrome, Simpson-Golabi-Behmel syndrome, CLOVES syndrome, and Sotos syndrome (1)
  • Nonovergrowth syndromes: Denys-Drash and Frasier, WAGR, sporadic, familial WT, Bohring-Opitz syndrome, Bloom syndrome, Li-Fraumeni syndrome, Fanconi anemia, Alagille syndrome, trisomy 18, and genitourinary anomalies (1)

-- To view the remaining sections of this topic, please or --

Basics

Description

  • The most common renal tumor in children; fifth most common pediatric malignancy
  • An embryonal renal neoplasm containing blastemal, stromal, or epithelial cell types
  • System(s) affected: renal/urologic
  • Synonym(s): nephroblastoma

Pediatric Considerations
Occurs predominately in children; rare incidence in late adolescence and adults

Epidemiology

Incidence

  • WT represents 6–7% of all childhood cancers and comprises 95% of renal cancers in children <15 years (1).
  • 650 cases diagnosed annually; incidence of 8.2 cases per 1 million children (1)
  • Median age of diagnosis is 36.5 months (1).

Etiology and Pathophysiology

Genetics

  • Tumors display recurrent gene mutations involved in either early renal development or epigenetic regulation (e.g., chromatin modification, transcription regulation, miRNA) (1).
  • 1/3 of tumors involve mutations of WT1, CTNNB1, or WTX genes (1).
  • Majority occur sporadically; familial inheritance <2% (1)

Risk Factors

More frequent in black children; rare in Asian (1)

General Prevention

Genetic counseling recommended for WT and one major abnormality: overgrowth syndromes, hemihyperplasia, aniridia, mental disability, diffuse mesangial sclerosis; or two minor malformations—inguinal or umbilical hernia, hypospadias, renal abnormalities, ectopic testis (1)

Commonly Associated Conditions

  • Overgrowth syndromes: Beckwith-Wiedemann syndrome, isolated hemihyperplasia, Perlman syndrome, Simpson-Golabi-Behmel syndrome, CLOVES syndrome, and Sotos syndrome (1)
  • Nonovergrowth syndromes: Denys-Drash and Frasier, WAGR, sporadic, familial WT, Bohring-Opitz syndrome, Bloom syndrome, Li-Fraumeni syndrome, Fanconi anemia, Alagille syndrome, trisomy 18, and genitourinary anomalies (1)

There's more to see -- the rest of this topic is available only to subscribers.